Would it surprise you to know that we bring innovation to the field of generic medicine? Or that our worldwide research and development group includes more than 2,900 scientists?
Today we manufacture bioequivalent versions of brand name medicines, many of which are difficult-to-manufacture and difficult-to-formulate. We strive to create enhanced versions of medicines to differentiate our products. We pursue innovations in oral solid dose medicines, transdermals, injectables, creams and ointments.
Why? Because we believe every disease can have a treatment. We believe every epidemic should come to an end. Medical conditions great and small should be manageable.